News

Sophia Shi, grad student with Carolyn Bertozzi and Tony Wyss-Coray, talks on her pioneering journey decoding how sugar molecules protect aging brains.

Stanford biochemist Lingyin Li’s lab is studying a tumor-fighting “miracle molecule” that could one day inform therapies for cancer, as well as autoimmune, neurodegenerative, and a

Stanford’s Gao Lab is leveraging AI to optimize the efficacy and safety of targeted cell and gene therapies.

The AAI ASPIRE Award recognizes up to six outstanding early career investigators for research accomplishments and professional promise in the field of immunology.

Stanley Qi & team have developed a technology that delivers RNA to damaged neurons and stimulates regrowth – paving the way for potential treatments for neurodegenerative disease.

Oxidizing chemicals break this cellular power plant into useless bits, leading to Parkinson’s disease, ALS, heart disease, diabetes, cancer and more. A small molecule could block t

Institute Scholar Stanley Qi is developing advanced gene-editing tools to treat life-threatening diseases and slow the onset of neurological aging.

By preserving a lipid critical to cellular cleanup, Institute Scholar Monther Abu-Remaileh and team improved a severe neurodegenerative condition in both cells and mice.

A technique developed by Institute Scholar Stanley Qi and W.E. Moerner to see DNA as it moves in living cells could offer novel fundamental insights into biology.

Institute Scholar Christopher Barnes won the Protein Science Young Investigator Award for bringing cutting-edge structural biology tools to bear on complex immunological problems.

Institute Scholar Polly Fordyce has been elected into the 2025 AIMBE College of Fellows for her distinguished achievements.

Institute Scholar Polly Fordyce has been elected into the 2025 class of AAAS Fellows for her distinguished contributions in bioengineering.

Rachel Brazil chats with Institute Scholar Paul Mischel about the ring-shaped extrachromosomal DNA that is implicated in many cancers.

CBI fellow Mikaela Ribi is one of 10 finalists chosen for Stanford’s first Three Minute Thesis competition.